Clinical Trials Browser

Phase 2 × Recurrence × Interleukin-2 × Clear all

NCT05883449 2025-08-20

LuminICE-203

Phase 2 Terminated

25 enrolled 21 charts

Hodgkin Disease, Recurrence, Lymphoma, T-Cell, Peripheral